A 2026 Guide to Reassessing Algorithmic Antitrust Risk
The U.S. Department of Justice’s recent proposed settlement with a revenue management software provider provides a guide for companies reassessing their antitrust risk associated with using algorithmic pricing vendors.
Risk assessments are highly fact-specific and vary by industry and market structure, so companies should engage experienced antitrust counsel to evaluate their use of algorithmic tools and the associated vendor practices.
Most algorithmic pricing matters arise under Section 1 of the Sherman Act, which prohibits agreements that restrain trade. Traditional price-fixing is per se illegal. Other conduct—such as sharing competitively sensitive information directly with competitors or indirectly through third parties like survey firms or pricing software—has generally been evaluated under the rule of reason. However, there remains limited formal DOJ and FTC guidance delineating permissible versus impermissible algorithmic pricing and information sharing practices.
The closest guidance that agencies provided was the September 1993 Health Care Policy Statement[1] that provided an antitrust “safety zone” for hospitals to exchange price and cost information if certain requirements were satisfied. The guidance was issued as part of a then-White House priority to make healthcare more available and affordable. There was concern that healthcare providers had delayed cooperative cost-cutting arrangements because of uncertainty about antitrust restrictions. The “safety zone” requirements, listed below, were essentially designed to prevent competitors from reverse engineering each other’s competitively sensitive price or wage information shared through surveys:
Approximately 20 years after the “safety zone” was created, DOJ revoked it. DOJ’s press release revoking the guidelines called them “outdated” and noted they were now “overly permissive on certain subjects, such as information sharing.” An accompanying speech by a high-ranking Antitrust Division official, Doha Mekki, cited the application of the guidelines outside of healthcare and the use of AI and machine learning on data as two reasons for withdrawing the guidance. Reading between the lines, AI and machine learning were making old data more valuable and were making it easier, with a sufficiently large dataset, to identify previously de-identifiable data.
Until DOJ’s recent—and first—proposed settlement agreement with a revenue management software provider to resolve algorithmic pricing allegations, the agencies have provided little guidance on how companies could use algorithmic pricing software without violating the antitrust laws. As part of the proposed settlement, the software provider agreed to a number of restrictions, including that it must do the following[2]:
Although industry-specific, these restrictions illuminate broader risk themes for companies utilizing algorithmic pricing. Conduct that presents the highest antitrust risk includes direct or indirect sharing of nonpublic competitive information among rivals; pooling of nonpublic data to train or operate models; using nonpublic data to generate real-time or near-real-time recommendations; surfacing granular trend insights from nonpublic inputs; and implementing product features that harden price floors or otherwise stabilize market outcomes. Companies should scrutinize whether their vendors engage in any of these practices.
Antitrust risks are not limited to pricing algorithms. As algorithms and AI continue to evolve, so do the potential antitrust risks associated with using them. When rivals are also using the same software vendors that employ algorithms or AI, companies should be aware of and evaluate the risks associated with using any software that determines output quantities or rates, allocates customers or geographies, recommends wages, or determines bid amounts.
In light of the DOJ’s proposed settlement and the agencies’ skepticism toward legacy “safety zones,” companies should proactively reassess their algorithmic software vendor risk:
The bottom line is the enforcement formal guidance is sparse, the environment is shifting, and algorithms can magnify traditional antitrust risks. A careful, recurring review of algorithmic software vendors, data pipelines, and vendor practices—with advice from experienced antitrust counsel—remains the most effective way to mitigate exposure while preserving the benefits of modern technology.
Endnotes
[1] See also DOJ and FTC Policy Statement (Aug. 1996).
[2] See DOJ Press Release (Nov. 24, 2025).
The information provided is not intended to be a comprehensive review of all developments in the law and practice, or to cover all aspects of those referred to.
Readers should take legal advice before applying it to specific issues or transactions.
Editorial Disclaimer
Originally published before the Ashurst Perkins Coie combination. See disclaimer.